Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
Clinical trial NCT06362317 · UNKNOWN
Trial details
- NCT number
- NCT06362317
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-06
- Primary completion
- 2025-03-06
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.